Flash Finance

Kovai MedicalKOVAICorporate

Healthcare Latest results: Jun 2026 14 quarters of data
Consolidated Standalone
₹5,973.00
MCap ₹6,536 Cr · P/E 25.5
Kovai Medical — Stock analysis & AI research Kovai Medical — Seasonality — best & worst months Kovai Medical — Technical indicators & charts Kovai Medical — Technical setup — score, trend, support & resistance Kovai Medical — Rising Wedge pattern forming Kovai Medical — Live exchange announcements
📋 High ROCE Stocks📋 High Operating Margin Stocks📋 High Interest Coverage Stocks📋 High Profit Growth Stocks📋 GARP Stocks (PEG Below 1)📋 Quality Stocks 🏭 Healthcare sector
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹431 Cr
Sales · Jun 2026
+15.3% YoY
₹124 Cr
Operating Profit · Jun 2026
+17.2% YoY
28.8%
OPM % · Jun 2026
+1.8% YoY
₹69 Cr
Net Profit · Jun 2026
+20.6% YoY
₹63.14
EPS · Jun 2026
+20.7% YoY

📝 Kovai Medical — results explained

Quarter ended June 2026 (Q1 FY27)

Kovai Medical reported revenue of ₹431 crore for the quarter ended June 2026 (Q1 FY27), up 15.3% from ₹374 crore in the same quarter last year, and up 4.1% sequentially over the March 2026 quarter.

Net profit rose 20.6% year-on-year to ₹69 crore, from ₹57 crore. Earnings per share (EPS) came in at ₹63.14.

Operating profit stood at ₹124 crore — an operating margin (OPM) of 28.8%, compared with 28.3% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Kovai Medical posted revenue of ₹1,587 crore, a growth of 15.7% over FY25, with a net profit of ₹244 crore (up 16.7% year-on-year).

On a trailing-twelve-month (TTM) basis, revenue stands at ₹1,644 crore with a net profit of ₹256 crore.

Valuation snapshot

At the current price of ₹5,973.00, KOVAI has a market capitalisation of ₹6,536 crore and a trailing P/E of about 25.5.

Within the Healthcare industry, it is the 7th-largest of the 22 companies we track by market value.

Shareholding pattern

As of Mar 2026, promoters held 56.53%, foreign institutional investors (FIIs) 1.21%, domestic institutional investors (DIIs) 4.47%, public shareholders 37.80% of Kovai Medical.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹6,536 Cr
Current Price ?
₹5,973.0
P/E ?
25.54below ind
Industry P/E ?
34.70
P/B ?
4.96
P/S ?
3.98
P/FCF ?
58.88
Enterprise Value ?
₹6,939 Cr
EV/EBITDA ?
15.15
PEG ?
0.91
Earnings Yield ?
4.9%
Dividend Yield ?
0.16%
Profitability & Returns
Sales (TTM) ?
₹1,644 Cr
OPM ?
27.9%
Profit after tax (TTM) ?
₹256 Cr
EPS (TTM) ?
₹233.85
ROCE ?
22.0%
ROE ?
19.4%
ROA ?
12.4%
Growth
Sales — latest qtr ?
₹431 Cr
PAT — latest qtr ?
₹69 Cr
YoY qtr sales growth ?
15.3%
YoY qtr profit growth ?
20.6%
Sales growth (3y) ?
16%
Sales growth (5y) ?
18%
Profit growth (3y) ?
28%
Profit growth (5y) ?
26%
Financial Health
Debt ?
₹403 Cr
Debt to Equity ?
0.31
Interest Coverage ?
10.2
Current Ratio ?
N/A
Ownership
Promoter holding ?
56.53%
Change in promoter holding ?
-0.02%
Pledged percentage ?
N/A
Market
Return 3 months ?
-0.2%
Return 6 months ?
131.8%

🗓️ Quarterly results (14 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best
Metric Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 YoY % QoQ %
Sales 267275303321321315344355357374392407414431 +15.3% +4.1%
Operating Profit 67688596928696103101106107116111124 +17.2% +11.7%
Other Income 56456556666787 +23.3% -12.5%
Interest 1010877789999868 -12.8% +33.3%
Depreciation 2222232324242425252627282932 +23.4% +10.3%
Profit Before Tax 4142587167616775747678878492 +20.4% +9.5%
Net Profit 3131435352465158555759656369 +20.6% +9.5%
EPS 27.9328.3839.6748.5247.6941.8146.3252.8349.9952.3053.7959.4257.8963.14 +20.7% +9.1%
OPM % 25.1% 24.9% 28.2% 30.0% 28.7% 27.4% 27.8% 29.0% 28.3% 28.3% 27.3% 28.5% 26.8% 28.8% +1.8% +7.5%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric FY25 FY26 TTM YoY %
Sales ₹1,371 Cr ₹1,587 Cr ₹1,644 Cr +15.7%
Operating Profit ₹386 Cr ₹440 Cr ₹458 Cr +14.0%
OPM % 28.13% 27.71% 27.86% -1.5%
NPM % 15.26% 15.38% 15.56% +0.8%
Other Income ₹22 Cr ₹27 Cr ₹29 Cr +25.9%
Depreciation ₹98 Cr ₹109 Cr ₹115 Cr +11.5%
Interest ₹33 Cr ₹32 Cr ₹31 Cr -2.1%
EBIT ₹288 Cr ₹330 Cr ₹343 Cr +14.9%
PBT ₹277 Cr ₹325 Cr ₹341 Cr +17.4%
Tax ₹49 Cr ₹60 Cr ₹41 Cr +23.1%
Net Profit ₹209 Cr ₹244 Cr ₹256 Cr +16.7%
EPS ₹190.95 ₹223.40 ₹234.24 +17.0%
Material Cost ₹274 Cr ₹308 Cr ₹211 Cr +12.4%
Employee Cost ₹185 Cr ₹226 Cr ₹155 Cr +21.8%
Extraordinary Items — — — —

🏛️ Balance Sheet (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Equity Capital 11111111 +0.0%
Reserves 7088781,0751,308 +21.7%
Borrowings 511310415403 -2.9%
Other Liabilities 209240299344 +15.1%
Total Liabilities 1,4391,4391,8012,066 +14.7%
Fixed Assets 1,0881,1181,2831,474 +14.9%
CWIP 2339154135 -12.3%
Investments 0001 —
Other Assets 328282364457 +25.5%
Total Assets 1,4391,4391,8012,066 +14.7%

💧 Cash Flow (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity 263344353362 +2.5%
Cash from Investing Activity -358-290-612-230 +62.4%
Cash from Financing Activity -86-24362-58 -193.5%
Net Cash Flow -180-189-19773 +137.1%
Free Cash Flow 1362061111 +11000.0%
CFO/OP 110%116%106%102% -3.8%

➗ Ratios (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Debtor Days 8589 +12.5%
Inventory Days 18171616 +0.0%
Days Payable 35302920 -31.0%
Cash Conversion Cycle -9-7-55 +200.0%
Working Capital Days -48-49-57-58 -1.8%
ROCE % 17%23%23%22% -4.3%

👥 Shareholding (latest 4 periods)

Metric Jun 2025Sep 2025Dec 2025Mar 2026 % Chg
Promoters 56.55%56.52%56.53%56.53% +0.0%
FIIs 1.27%1.25%1.31%1.21% -7.6%
DIIs 4.52%4.89%4.73%4.47% -5.5%
Public 37.65%37.34%37.43%37.80% +1.0%
No. of Shareholders 17,65018,68118,64418,864 +1.2%

⚖️ Peer comparison

Industry: Healthcare · 22 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 VIJAYA Vijaya Diagnostic ₹1,507.80 15,530 82.7 857 187 42.3% 21.8% 19.5% 20.2% 22.8% 37.3%
2 METROPOLIS Metropolis Healthcare ₹596.30 12,370 61.1 1,710 203 24.7% 11.9% 23.6% 31.4% 16.6% 25.7%
3 HCG Healthcare Global ₹704.05 10,512 390.9 2,626 33 18.2% 1.3% 14.6% -53.3% 13.1% 175.3%
4 YATHARTH Yatharth Hospital ₹988.90 9,528 54.1 1,200 171 23.6% 14.3% 36.2% 31.6% 47.6% 16.2%
5 JLHL Jupiter Life ₹277.85 9,109 9.7 1,557 187 22.1% 12.0% 20.9% -6.7% 18.2% -14.5%
6 THYROCARE Thyrocare Technologies ₹555.45 8,841 50.0 876 176 32.1% 20.1% 20.8% 79.4% 24.3% 33.2%
7 KOVAI Kovai Medical ₹6,260.50 6,850 26.7 1,644 256 27.9% 15.6% 15.7% 16.7% 15.3% 20.6%
8 INDRAMEDCO Indraprastha Medical ₹363.20 3,330 17.7 1,524 188 18.0% 12.4% 9.3% 13.7% 11.3% 9.5%
9 KRSNAA Krsnaa Diagnostics ₹543.40 1,763 18.1 816 98 26.8% 12.0% 7.8% 31.0% 22.1% -19.3%
10 SURAKSHA Suraksha Diagnostic ₹311.85 1,624 45.3 325 35 31.4% 10.8% 23.1% 1.4% 20.7% 40.0%
11 SHALBY Shalby ₹132.15 1,418 38.0 1,176 37 12.1% 3.2% 5.0% 1683.0% 11.7% 36.7%
12 GPTHEALTH GPT Healthcare ₹157.90 1,296 27.4 491 48 18.5% 9.8% 15.1% -21.9% 17.8% 62.5%
13 LAXMIDENTL Laxmi Dental ₹196.21 1,080 35.0 287 31 16.2% 10.9% 16.0% -10.1% 13.2% 28.9%
14 NEPHROCARE Nephro Care ₹234.80 387 — — — — — — — 68.4% 347.7%
15 LOTUSEYE Lotus Eye ₹114.50 243 n/m 57 0 8.5% 0.3% 8.4% -89.1% 26.2% 13.0%
16 UNIHEALTH Unihealth Hospitals ₹121.00 190 6.5 132 46 40.9% 34.8% — — 104.6% 71.5%
17 MADHAVBAUG Vaidya Sane ₹148.00 156 19.1 147 8 11.4% 5.6% — — 116.1% 94.3%
18 MHHL Mohini Health ₹57.05 104 — 145 -17 -1.4% -11.7% — — -6.6% -1400.0%
19 MAITREYA Maitreya Medicare ₹120.65 82 — 45 -2 -1.0% -5.5% — — -5.2% -1720.0%
20 AATMAJ Aatmaj Healthcare ₹26.75 60 83.6 24 1 9.7% 2.9% — — 22.5% -39.4%
21 NIDAN Nidan Laborator. ₹33.00 46 30.6 26 2 19.0% 5.9% — — -11.2% -92.0%
22 ARTEMISMED Artemis Medicare ₹315.00 — 48.0 1,081 103 17.4% 9.6% 15.4% 25.9% 16.3% 30.9%
❓ Frequently asked questions
What was Kovai Medical's revenue in Q1 FY27?
Kovai Medical reported revenue of ₹431 crore for the quarter ended June 2026 (Q1 FY27), up 15.3% from ₹374 crore in the same quarter last year, and up 4.1% sequentially over the March 2026 quarter.
What was Kovai Medical's net profit in Q1 FY27?
Net profit rose 20.6% year-on-year to ₹69 crore, from ₹57 crore. Earnings per share (EPS) came in at ₹63.14.
What is KOVAI's market capitalisation and P/E ratio?
At the current price of ₹5,973.00, KOVAI has a market capitalisation of ₹6,536 crore and a trailing P/E of about 25.5.
Who owns Kovai Medical? (shareholding pattern)
As of Mar 2026, promoters held 56.53%, foreign institutional investors (FIIs) 1.21%, domestic institutional investors (DIIs) 4.47%, public shareholders 37.80% of Kovai Medical.
TTM ends 2026-06-30. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI